Search Count: 22
 |
Main Protease Of Hku4 In Complex With Avi-8122
Organism: Tylonycteris bat coronavirus hku4
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2026-02-18 Classification: VIRUS Ligands: A1BWH |
Organism: Tylonycteris bat coronavirus hku4
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH
 |
Sars-Cov-2 Main Protease In Complex With Avi-8122
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1BWH |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH
 |
Crystal Structure Of Main Protease Of Pedv In Complex With Avi8122
Organism: Porcine epidemic diarrhea virus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1BWH |
Organism: Porcine epidemic diarrhea virus
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH
 |
Camel Alphacoronavirus (229E-Like) Nsp5 In Complex With Avi8122
Organism: Camel alphacoronavirus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1BWH, PEG |
Organism: Camel alphacoronavirus
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH, PEG
 |
Main Protease Of Mers In Complex With Avi8122
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1BWH |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH
 |
Main Protease Of Hku8 In Complex With Avi8122
Organism: Miniopterus bat coronavirus hku8
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1BWH |
Organism: Miniopterus bat coronavirus hku8
Method: X-RAY DIFFRACTION
Release Date: 2026-02-18
Ligands: A1BWH
 |
Crystal Structure Of Main Protease Of Sars-Cov-2 Complexed With Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-03-12 Classification: VIRAL PROTEIN Ligands: V8X |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-03-12
Ligands: V8X
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-12-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTM |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-12-07
Ligands: XTM
 |
Peptidomimetic Nitrile Warheads As Sars-Cov-2 3Cl Protease Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-09-01 Classification: VIRAL PROTEIN Ligands: 4IT |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-09-01
Ligands: 4IT
 |
Structure Of Sars-Cov2 3Cl Protease Covalently Bound To Peptidomimetic Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-07-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: YWJ, FN7 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: YWJ, FN7
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTJ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTJ
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XTP |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XTP
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XU4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XU4
 |
Improved Feline Drugs As Sars-Cov-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization For Enhanced Bioavailability
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: XV4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-07-07
Ligands: XV4
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: K36 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: K36
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor Ligands: UED |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: UED
 |
Feline Coronavirus Drug Inhibits The Main Protease Of Sars-Cov-2 And Blocks Virus Replication
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-05-20 Classification: Hydrolase/Hydrolase Inhibitor |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
 |
Thermus Aquaticus Succinyl-Coa Synthetase In Complex With Gdp-Mn2+
Organism: Thermus aquaticus
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2012-06-27 Classification: LIGASE Ligands: GDP, MN |
Organism: Thermus aquaticus
Method: X-RAY DIFFRACTION
Release Date: 2012-06-27
Ligands: GDP, MN
 |
E. Coli Scs
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2002-01-30 Classification: LIGASE Ligands: PO4, COA, GOL, SO4 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2002-01-30
Ligands: PO4, COA, GOL, SO4
 |
Crystal Structure Analysis Of The E197Betaa Mutant Of E. Coli Scs
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2002-01-30 Classification: LIGASE Ligands: PO4, COA, SO4 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2002-01-30
Ligands: PO4, COA, SO4